Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Ernexa Therapeutics Inc. ERNAW

Full chart Compare
Set alert

Price alert · ERNAW

All alert types
0.03 USD +0.01 (+22.66%)

Nov 6, 2026, 9:31 AM EST

0.0256 Day range 0.0369
0.0256 52-week range 0.0314
YTD
+22.66%
1 year
+22.66%

Financial health

Altman Z-Score

-55.06 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -0.5×
FY 2016: -83.0×FY 2017: -143×FY 2018: -304×FY 2019: -46.3×FY 2020: -383×FY 2021: -22.1×FY 2022: -6.0×FY 2023: -6.6×FY 2024: -2.8×FY 2025: -0.5×
FY 2016 5y median -6.0× FY 2025
P/S 0.0×
FY 2016: 10.9×FY 2017: 7.2×FY 2018: 3.4×FY 2019: 4.8×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 2110×FY 2024: 215×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.2×
FY 2016: 59.6×FY 2017: 27.9×FY 2018: 11.4×FY 2019: 18.6×FY 2020: 304×FY 2021: 106×FY 2022: 12.2×FY 2023: 64.3×FY 2024: 73.6×FY 2025: 3.2×
FY 2016 5y median 64.3× FY 2025
P/FCF -1.1×
FY 2016: -297×FY 2017: -171×FY 2018: -318×FY 2019: 57.5×FY 2020: -286×FY 2021: -115×FY 2022: -6.9×FY 2023: -7.0×FY 2024: -7.7×FY 2025: -1.1×
FY 2016 5y median -7.0× FY 2025
EV/EBITDA -0.4×
FY 2016: 403×FY 2017: 171×FY 2018: 24.7×FY 2019: 69.9×FY 2020: -88.3×FY 2021: -22.1×FY 2022: -5.8×FY 2023: -8.9×FY 2024: -3.4×FY 2025: -0.4×
FY 2016 5y median -5.8× FY 2025
EV/Sales 0.0×
FY 2016: 11.0×FY 2017: 7.3×FY 2018: 3.4×FY 2019: 4.9×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 2614×FY 2024: 213×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -93.2%
FY 2016: -0.3%FY 2017: -0.6%FY 2018: -0.3%FY 2019: 1.7%FY 2020: -0.3%FY 2021: -0.9%FY 2022: -14.4%FY 2023: -14.2%FY 2024: -12.9%FY 2025: -93.2%
FY 2016 5y median -14.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 63.6%FY 2017: 66.7%FY 2018: 64.1%FY 2019: 60.4%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -247.1%FY 2024: 83.5%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -10.2%FY 2017: -6.6%FY 2018: 2.0%FY 2019: -6.1%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -31080.9%FY 2024: -2693.1%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -13.1%FY 2017: -5.1%FY 2018: -1.1%FY 2019: -10.3%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -31864.7%FY 2024: -7652.7%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -586.6%
FY 2016: -71.9%FY 2017: -19.5%FY 2018: -3.7%FY 2019: -40.2%FY 2020: 155.5%FY 2021: -480.5%FY 2022: -203.0%FY 2023: -970.4%FY 2024: -2618.4%FY 2025: -586.6%
FY 2016 5y median -586.6% FY 2025
ROIC -316.6%
FY 2016: -16.7%FY 2017: -12.7%FY 2018: 3.1%FY 2019: -9.8%FY 2020: -68.5%FY 2021: -402.2%FY 2022: -199.3%FY 2023: -47.2%FY 2024: -617.6%FY 2025: -316.6%
FY 2016 5y median -316.6% FY 2025
ROA -241.4%
FY 2016: -17.1%FY 2017: -6.5%FY 2018: -1.7%FY 2019: -13.4%FY 2020: 92.3%FY 2021: -388.7%FY 2022: -110.3%FY 2023: -44.1%FY 2024: -845.3%FY 2025: -241.4%
FY 2016 5y median -241.4% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: -9.0%FY 2017: -4.7%FY 2018: 9.7%FY 2019: -15.1%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 755.9%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income 40.5%
FY 2016: 65.5%FY 2017: 38.5%FY 2018: 133.1%FY 2019: -361.2%FY 2020: -498.0%FY 2021: -1469.2%FY 2022: 70.8%FY 2023: 36.4%FY 2024: 25.8%FY 2025: 40.5%
FY 2016 FY 2025
EPS (diluted) -42.7%
FY 2016: 60.9%FY 2017: 71.3%FY 2018: 78.2%FY 2019: -639.7%FY 2020: 87.7%FY 2021: -1512.8%FY 2022: 85.8%FY 2023: 49.4%FY 2024: 61.5%FY 2025: -42.7%
FY 2016 FY 2025
Free Cash Flow 56.5%
FY 2016: 85.9%FY 2017: -10.5%FY 2018: 72.6%FY 2019: 768.0%FY 2020: -593.3%FY 2021: -190.4%FY 2022: 10.0%FY 2023: 4.0%FY 2024: 20.7%FY 2025: 56.5%
FY 2016 FY 2025

Financial Health

Current Ratio 1.0×
FY 2016: 1.6×FY 2017: 0.9×FY 2018: 1.7×FY 2019: 1.0×FY 2020: 0.6×FY 2021: 5.1×FY 2022: 1.8×FY 2023: 1.5×FY 2024: 0.8×FY 2025: 1.0×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.0×
FY 2016: 1.2×FY 2017: 0.4×FY 2018: 1.1×FY 2019: 0.8×FY 2020: 0.6×FY 2021: 5.1×FY 2022: 1.8×FY 2023: 1.5×FY 2024: 0.8×FY 2025: 1.0×
FY 2016 5y median 1.5× FY 2025
Debt / Equity 0.2×
FY 2016: 2.1×FY 2017: 1.0×FY 2018: 0.6×FY 2019: 1.2×FY 2020: 0.4×FY 2021: 0.1×FY 2022: 0.3×FY 2023: 18.7×FY 2024: 0.4×FY 2025: 0.2×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: 4.7×FY 2017: 2.2×FY 2018: 0.4×FY 2019: 2.0×FY 2020: -0.0×FY 2021: 0.1×FY 2022: 0.3×FY 2023: -1.7×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage -345×
FY 2016: -4.0×FY 2017: -2.8×FY 2018: 1.2×FY 2019: -4.9×FY 2020: -169×FY 2021: -1537×FY 2022: -1107×FY 2023: -34.4×FY 2024: -2.3×FY 2025: -345×
FY 2016 5y median -345× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -0.5%FY 2017: -1.5%FY 2018: -6.2%FY 2019: -0.8%FY 2020: 0.0%FY 2021: -0.0%FY 2022: -0.1%FY 2023: -0.1%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31